TrialHuman vaccines & immunotherapeutics2014

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma.

Koichi Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.